pargyline has been researched along with Hyperactivity, Motor in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morinan, A | 1 |
| Collier, JG | 1 |
| Olds, ME | 1 |
| Yuwiler, A | 1 |
2 other studies available for pargyline and Hyperactivity, Motor
| Article | Year |
|---|---|
Effects of pargyline and SKF-525A on brain N,N-dimethyltryptamine concentrations and hyperactivity in mice.
Topics: Animals; Brain; Drug Synergism; Humans; Hyperkinesis; Male; Mice; N,N-Dimethyltryptamine; Pargyline; | 1981 |
Comparison of hyperactivity in adult rats induced by neonatal intraventricular 6-hydroxydopamine following pargyline or desmethylimipramine treatment.
Topics: Age Factors; Animals; Animals, Newborn; Brain; Desipramine; Dopamine; Female; Hydroxydopamines; Hype | 1985 |